89 related articles for article (PubMed ID: 9145212)
1. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
Konishi T; Takahashi M; Ohta S
Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
[TBL] [Abstract][Full Text] [Related]
2. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
Konishi T
Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
[TBL] [Abstract][Full Text] [Related]
3. A new simple test for evaluation of intestinal bacteria.
Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
[TBL] [Abstract][Full Text] [Related]
4. Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.
Takahashi M; Maeda Y; Tashiro H; Akazawa F; Okajima M; Yoshioka S; Matsugu Y; Toyota K; Masaoka Y
Scand J Gastroenterol; 1991 Jun; 26(6):577-88. PubMed ID: 1862298
[TBL] [Abstract][Full Text] [Related]
5. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
[TBL] [Abstract][Full Text] [Related]
6. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
Maeda Y; Takahashi M; Tashiro H; Akazawa F
J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
[TBL] [Abstract][Full Text] [Related]
7. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
Maeda Y; Takahashi M
J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
Batta AK; Tint GS; Xu G; Shefer S; Salen G
J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies of benzalazine.
Herzog R; Leuschner J
Arzneimittelforschung; 1994 Dec; 44(12):1381-3. PubMed ID: 7848362
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.
Maeda Y; Murakami T
Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830173
[TBL] [Abstract][Full Text] [Related]
11. Intestinal absorption and metabolism of homoursodeoxycholic acid in rats.
Kuramoto T; Moriwaki S; Kawamoto K; Hoshita T
J Pharmacobiodyn; 1987 Jul; 10(7):309-16. PubMed ID: 3694424
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of N-methylnitrosourea-induced colon carcinogenesis by ursodeoxycholic acid-5-aminosalicylic acid conjugate in F344 rats.
Narisawa T; Fukaura Y; Takeba N; Nakai K
Jpn J Cancer Res; 2002 Feb; 93(2):143-50. PubMed ID: 11856477
[TBL] [Abstract][Full Text] [Related]
13. Basic studies on N''-ursodeoxycholyldiethylenetriamine-N,N,N'-triacetic acid for the dissolution of calcified gallstones.
Takahashi M; Konishi T; Maeda Y; Fukuzawa M; Nishida T; Ohya T; Katayama K; Kakehi N; Sakakura H; Takagi A; Maeda M; Ohama H
Biol Pharm Bull; 1998 Jun; 21(6):551-7. PubMed ID: 9657036
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
15. Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine.
Kim H; Kim D; Choi D; Jeon H; Han J; Jung Y; Kong H; Kim YM
Drug Deliv; 2008 Jan; 15(1):37-42. PubMed ID: 18197522
[TBL] [Abstract][Full Text] [Related]
16. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
[TBL] [Abstract][Full Text] [Related]
18. Oroileal transit of slow release 5-aminosalicylic acid.
Goebell H; Klotz U; Nehlsen B; Layer P
Gut; 1993 May; 34(5):669-75. PubMed ID: 8504969
[TBL] [Abstract][Full Text] [Related]
19. [The ursodeoxycholic acid-p-aminobenzoic acid test in the diagnosis of small bowel bacterial overgrowth syndrome].
Kiss Z; Wölfling J; Csáti S; Nagy F; Lonovics J; Schneider G
Orv Hetil; 1997 May; 138(20):1255-8. PubMed ID: 9244859
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine.
Grisham MB; Granger DN
Dig Dis Sci; 1989 Apr; 34(4):573-8. PubMed ID: 2702889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
